Pharmaceutical News & Resources

XTALKS PRESS RELEASE FOR Nitto Avecia Pharma (April 17/18 Webinar)

April 17th, 2018 by aveciapharma

HEADLINE Cell-Based Assays in a CGMP Environment: Approaches for Clinical and Commercial Stability Studies, New Webinar Hosted by Xtalks. SUB-HEADLINE Presentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP and ) and...

Read Full Story »

Posted in: Press Release

Avecia Announces Opening of Cambridge, MA Office

February 1st, 2018 by aveciapharma

CAMBRIDGE, MA – Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible...

Read Full Story »

Posted in: Company News, Press Release

Nitto Avecia Pharma Services Appoints Raymond Kaczmarek as President

January 15th, 2018 by aveciapharma

NITTO AVECIA PHARMA SERVICES APPOINTS RAYMOND KACZMAREK AS PRESIDENT IRVINE, CA – Nitto Avecia Pharma Services, Inc. (Avecia Pharma), a leading CGMP contract development and manufacturing organization (CDMO), announced today that it has appointed Raymond Kaczmarek to the position of President....

Read Full Story »

Posted in: Company News, Press Release

Nitto Avecia Completes Multiple Successful Oligonucleotide Manufacturing Synthesis Runs at 1.6 Mol Scale

November 7th, 2017 by aveciapharma

MILFORD, MA – Nitto Avecia, Inc. (Avecia) announced today the successful completion of the first synthesis runs at the 1.6 Mol scale which is believed to be the largest synthesis scale ever executed for oligonucleotide API (active pharmaceutical ingredients) at its new oligonucleotide manufacturing facility...

Read Full Story »

Posted in: Press Release

Nitto Avecia Announces Multiple Oligonucleotide Expansions

November 14th, 2016 by aveciapharma

MILFORD, MA – Nitto Avecia Inc. (Avecia) today released its progress in expanding the company’s analytical development and oligonucleotide manufacturing capacities. The announcement signals the continuation of Avecia’s robust growth strategy to significantly increase its oligonucleotide...

Read Full Story »

Posted in: Press Release

Nitto Denko Avecia, Inc. Acquires the Businesses of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals

October 11th, 2016 by aveciapharma

MILFORD, MA – Nitto Denko Avecia, Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services...

Read Full Story »

Posted in: Company News, Press Release


Back to Top
Cal. Civ. Code § 1798.102 - Do Not Sell My Personal Information